GoggleDocs (@goggledocs) 's Twitter Profile
GoggleDocs

@goggledocs

🥽🩺Docs/nurses/pharmacists from U.K. Talking CardioRenoMetabolic & more Catch us on YouTube youtube.com/c/GoggleDocs |Educate, Motivate, Activate!

ID: 1313928734144188419

calendar_today07-10-2020 19:46:43

2,2K Tweet

3,3K Takipçi

2,2K Takip Edilen

GoggleDocs (@goggledocs) 's Twitter Profile Photo
GoggleDocs
@goggledocs

a month ago

❗️Tirzepatide meets primary and secondary outcomes in its CVOT (SURPASS-CVOT)❗️ 🔹A first for CVOTs - comparing to dulaglutide (established benefit) 🔸Statistical analysis allows for comparison to putative placebo 🔹1ry outcome HR 0.92 p=0.086 🔸2ndry outcome HR 0.84 0=0.002

❗️Tirzepatide meets primary and secondary outcomes in its CVOT (SURPASS-CVOT)❗️ 🔹A first for CVOTs - comparing to dulaglutide (established benefit) 🔸Statistical analysis allows for comparison to putative placebo 🔹1ry outcome HR 0.92 p=0.086 🔸2ndry outcome HR 0.84 0=0.002